(Total Views: 747)
Posted On: 06/02/2024 8:53:55 PM
Post# of 148870
"$1.6 billion Long Covid initiative has failed so far to meet its goals"
It's time for Leronlimab to save the day and help all the Long Covid sufferers out there (estimated to be more than 65 million people worldwide and growing!). Worth reading:
https://thesicktimes.org/2024/05/31/they-bung...its-goals/
Here's Dr. Jay on last week's CYDY shareholder conference call:
"...importantly the clinical endpoint data from the cd15 Long Covid trial was recently published in the Journal of Infection. That study enrolled 56 patients with Long Covid who were treated for eight weeks with either Leronlimab or placebo. And the study results showed clinical Improvement in 19 of the 24 endpoints that were evaluated. So that data is now posted on our website and has been brought to the attention of colleagues at the recover program at NIH, overseeing studies in Long Covid. "
I remain... #BULLISH!
It's time for Leronlimab to save the day and help all the Long Covid sufferers out there (estimated to be more than 65 million people worldwide and growing!). Worth reading:
https://thesicktimes.org/2024/05/31/they-bung...its-goals/
Here's Dr. Jay on last week's CYDY shareholder conference call:
"...importantly the clinical endpoint data from the cd15 Long Covid trial was recently published in the Journal of Infection. That study enrolled 56 patients with Long Covid who were treated for eight weeks with either Leronlimab or placebo. And the study results showed clinical Improvement in 19 of the 24 endpoints that were evaluated. So that data is now posted on our website and has been brought to the attention of colleagues at the recover program at NIH, overseeing studies in Long Covid. "
I remain... #BULLISH!
(19)
(0)Scroll down for more posts ▼
